Sven‐Ulrik Gorr

This study evaluates modifications to the antimicrobial peptide DGL13K to improve its therapeutic properties, finding that the native sequence is already highly optimized.

This study shows that exposure to antimicrobial peptides DGL13K and LGL13K leads to different resistance mechanisms in Staphylococcus aureus, with DGL13K selecting for resistance to LGL13K but not itself.

This study identifies synonymous mutations in hagA that confer resistance to DGL13K in P. gingivalis by altering mRNA structure and reducing HagA expression, without affecting mRNA levels.